scholarly journals The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis

2016 ◽  
Vol 20 (22) ◽  
pp. 1-250 ◽  
Author(s):  
Malcolm J Price ◽  
AE Ades ◽  
Kate Soldan ◽  
Nicky J Welton ◽  
John Macleod ◽  
...  

Background and objectivesThe evidence base supporting the National Chlamydia Screening Programme, initiated in 2003, has been questioned repeatedly, with little consensus on modelling assumptions, parameter values or evidence sources to be used in cost-effectiveness analyses. The purpose of this project was to assemble all available evidence on the prevalence and incidence ofChlamydia trachomatis(CT) in the UK and its sequelae, pelvic inflammatory disease (PID), ectopic pregnancy (EP) and tubal factor infertility (TFI) to review the evidence base in its entirety, assess its consistency and, if possible, arrive at a coherent set of estimates consistent with all the evidence.MethodsEvidence was identified using ‘high-yield’ strategies. Bayesian Multi-Parameter Evidence Synthesis models were constructed for separate subparts of the clinical and population epidemiology of CT. Where possible, different types of data sources were statistically combined to derive coherent estimates. Where evidence was inconsistent, evidence sources were re-interpreted and new estimates derived on a post-hoc basis.ResultsAn internally coherent set of estimates was generated, consistent with a multifaceted evidence base, fertility surveys and routine UK statistics on PID and EP. Among the key findings were that the risk of PID (symptomatic or asymptomatic) following an untreated CT infection is 17.1% [95% credible interval (CrI) 6% to 29%] and the risk of salpingitis is 7.3% (95% CrI 2.2% to 14.0%). In women aged 16–24 years, screened at annual intervals, at best, 61% (95% CrI 55% to 67%) of CT-related PID and 22% (95% CrI 7% to 43%) of all PID could be directly prevented. For women aged 16–44 years, the proportions of PID, EP and TFI that are attributable to CT are estimated to be 20% (95% CrI 6% to 38%), 4.9% (95% CrI 1.2% to 12%) and 29% (95% CrI 9% to 56%), respectively. The prevalence of TFI in the UK in women at the end of their reproductive lives is 1.1%: this is consistent with all PID carrying a relatively high risk of reproductive damage, whether diagnosed or not. Every 1000 CT infections in women aged 16–44 years, on average, gives rise to approximately 171 episodes of PID and 73 of salpingitis, 2.0 EPs and 5.1 women with TFI at age 44 years.Conclusions and research recommendationsThe study establishes a set of interpretations of the major studies and study designs, under which a coherent set of estimates can be generated. CT is a significant cause of PID and TFI. CT screening is of benefit to the individual, but detection and treatment of incident infection may be more beneficial. Women with lower abdominal pain need better advice on when to seek early medical attention to avoid risk of reproductive damage. The study provides new insights into the reproductive risks of PID and the role of CT. Further research is required on the proportions of PID, EP and TFI attributable to CT to confirm predictions made in this report, and to improve the precision of key estimates. The cost-effectiveness of screening should be re-evaluated using the findings of this report.FundingThe Medical Research Council grant G0801947.

BMJ ◽  
2007 ◽  
Vol 335 (7614) ◽  
pp. 291 ◽  
Author(s):  
Tracy E Roberts ◽  
Suzanne Robinson ◽  
Pelham M Barton ◽  
Stirling Bryan ◽  
Anne McCarthy ◽  
...  

2020 ◽  
Author(s):  
Opeyemi Atanda ◽  
Patrick Callaghan ◽  
Eleni Vangeli ◽  
Paula Reavey ◽  
Tim Carter ◽  
...  

Abstract Background: Mental Health First Aid (MHFA) has received substantial international attention since its founding in the late 1990s, with a growing evidence base relating to its nature and impact across a variety of settings. Aims: To identify the effectiveness of MHFA upon a range of outcomes, recipients, its cost-effectiveness, and the mechanisms of its effect.Method: A systematic evidence synthesisResults: Data from 65 studies show MHFA education improves trainees’ mental health literacy, their perceived confidence in helping people living with mental distress and their intentions to help such people. MHFA also raises employees’ knowledge of mental illnesses in the workplace. There was also evidence of MHFA trainees using aspects of the five-stage ALGEE MHFA approach in their helping behaviour. The quality of the studies in this review varied across different types of studies. No published studies to date have evaluated MHFA’s impact on recipient outcomes, articulated the mechanisms of its effect, its cost-effectiveness, or societal impact.Conclusions: MHFA remains popular, but evidence of its effectiveness upon those receiving it remains unknown. It is urgent to undertake studies testing the effectiveness and cost-effectiveness of MHFA upon recipients, as well as identifying, empirically, how MHFA works, for whom, under what conditions, and barriers to its implementation. Given that the enthusiasm and acceptance of MHFA appears widespread, systematic evaluations of its social impact are warranted.Registration: The review protocol has been submitted to the Open Science Framework (View-only link: https://osf.io/rj4uh/?view_only=d1f9f2ed73724b3f8075c0c4581d0d87).


2005 ◽  
Vol 16 (12) ◽  
pp. 799-801 ◽  
Author(s):  
A S Menon-Johansson ◽  
A Winston ◽  
G Matthews ◽  
S Portsmouth ◽  
D Daniels

Our objective was to estimate Chlamydia trachomatis (CT) genital infection point prevalence in young male inmates using a non-invasive sampling technique. All new inmates were invited into the study that consisted of a questionnaire and the provision of a urine sample for analysis. The questionnaire asked about personal characteristics, sexual history and symptoms. CT was diagnosed using nucleic acid amplification tests. In all, 13% of new inmates were found to have CT infection. One-fifth of these CT-positive individuals had symptoms of urethral infection. CT prevalence among young male inmates is comparable with results obtained from young women in UK screening programmes. Numerous factors support the integration of CT screening in prisons into the national chlamydia screening programme.


Sexual Health ◽  
2013 ◽  
Vol 10 (1) ◽  
pp. 1 ◽  
Author(s):  
Mufiza Zia Kapadia

A systematic review was undertaken to estimate the prevalence of chlamydia (Chlamydia trachomatis) infection among those screened in community pharmacies. The uptake of screening and clients’ sociodemographic and behavioural characteristics were also reviewed. Eleven papers contributed to the final review. The proportional meta-analysis showed a chlamydia positivity of 8.1% (95% confidence interval: 7.3%–8.9%). Chlamydia screening programs in community pharmacies tended to be targeted at certain client groups such as those seeking emergency contraception in pharmacies. The pharmacists were reluctant to offer chlamydia screening to potential clients. The uptake of the service was much lower, and tended not to include men and ethnic minorities.


2009 ◽  
Vol 16 (2) ◽  
pp. 189-204 ◽  
Author(s):  
J.A. Land ◽  
J.E.A.M. Van Bergen ◽  
S.A. Morre ◽  
M.J. Postma

Sexual Health ◽  
2006 ◽  
Vol 3 (4) ◽  
pp. 225 ◽  
Author(s):  
Silke Walleser ◽  
Glenn Salkeld ◽  
Basil Donovan

Background: In Australia, there is no published study on the cost effectiveness of screening for chlamydia. The aim of this study was to examine the cost effectiveness of a hypothetical screening programme for chlamydia based on annual opportunistic testing of all women 25 years of age or younger consulting a general practitioner, compared with no screening. Methods: A decision–analytic modelling approach was used to determine the incremental cost effectiveness ratio (ICER) of screening compared with no screening over 25 years. The analysis measured Australian health-care costs and benefits were assessed in terms of quality-adjusted life years (QALYs). Results: The analysis resulted in a cost per QALY of $2968 for screening. One-way sensitivity analyses on all variables, and multi-way sensitivity analyses on some variables, showed a wide range for the cost effectiveness, from dominance (where screening is effective and saves money overall) to an ICER of $67 715 per QALY. Conclusions: The results indicate that annual opportunistic screening for chlamydia in women under 25 is a potentially worthwhile undertaking. However, the analysis also highlights uncertainties around the natural history of chlamydia and the effectiveness of chlamydia screening. Given these uncertainties, the need for further primary data collection in these areas becomes apparent.


Sign in / Sign up

Export Citation Format

Share Document